Company intelligence / Profile preview

Advantage Life Science Fund II

New Orleans, Louisiana, United States

Ownership: Private
Development stage: Other

Overview

Advantage Life Science Fund II is a venture capital fund managed by Advantage Capital that focuses on investing in early-to-late-stage life science companies. The fund specifically targets businesses in the biotechnology, medical device, and healthcare information technology sectors, often with a geographic focus on underserved states or regions. By providing growth capital and strategic support, the fund aims to accelerate the development of innovative medical solutions and foster economic growth within the life sciences ecosystem. Its portfolio typically includes companies working on novel therapeutics, diagnostic tools, and healthcare delivery platforms.

Industry: Investors

Beyond the preview

Go deeper on Advantage Life Science Fund II.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advantage Life Science Fund II.

Explore the full profile